GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

Data from the Gore ASSURED Clinical Study demonstrated 100 percent closure success at six months

Jun 4, 2019

Gore Receives FDA Approval for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL

The device and new delivery system combine proven conformability with enhanced placement control to optimize TEVAR outcomes in even complex aortic anatomy

May 15, 2019

Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium<sup>&reg;</sup>

Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts

Nov 6, 2018

First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry

Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies

Sep 12, 2018

Gore Acquires Pipeline Medical Technologies, Inc.

Acquisition of transcatheter mitral chordal repair technology builds on Gore’s structural heart capabilities

Sep 6, 2018

Gore Announces Successful Patient Implant of Endovascular Stent Graft for the Ascending Aorta

GORE® Ascending Stent Graft, an investigational device, is an off-the-shelf endovascular solution designed to treat life-threatening Type A dissections of the ascending aorta

Aug 27, 2018

GORE® Molding &amp; Occlusion Balloon for Endovascular Aortic Repair Receives Approval in the United States, Japan, and Europe

New balloon that addresses EVAR stent graft seal and temporary vessel occlusion challenges

Aug 23, 2018

Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR in Australia

New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft

Jul 24, 2018

FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone

Apr 3, 2018

First Patient Enrolled in Investigational Study of the GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System

Investigating the safety and effectiveness of a stent graft system designed to provide endovascular aneurysm repair (EVAR) with angulation control to patients previously considered untreatable

Jan 3, 2018